Jian-Hong Zhu

Prof. Jian-Hong Zhu

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2016 in Scientific Reports
Verified
Journal Article
Open access
JWJian-Yong Wang
Jian-Yong Wang
QZQing-Qing Zhuang
Qing-Qing Zhuang
LZLan-Bing Zhu
Lan-Bing Zhu
HZHui Zhu
Hui Zhu
TLTing Li
Ting Li
JZJian-Hong Zhu
Jian-Hong Zhu
Brain iron levels in patients of Parkinson’s disease (PD) are usually measured in postmortem samples or by MRI imaging including R2* and SWI. In this study we performed a meta-analysis to understand PD-associated iron changes in various brain regions, and to evaluate the accuracy of MRI detections comparing with postmortem results. Databases including Medline, Web of Science, CENTRAL and Embase were searched up to 19th November 2015. Ten brain regions were identified for analysis based on data extracted from thirty-three-articles. An increase in iron levels in substantia nigra of PD patients by postmortem, R2* or SWI measurements was observed. The postmortem and SWI measurements also suggested significant iron accumulation in putamen. Increased iron deposition was found in red nucleus as determined by both R2* and SWI, whereas no data were available in postmortem samples. Based on SWI, iron levels were increased significantly in the nucleus caudatus and globus pallidus. Of note, the analysis might be biased towards advanced disease and that the precise stage at which regions become involved could not be ascertained. Our analysis provides an overview of iron deposition in multiple brain regions of PD patients, and a comparison of outcomes from different methods detecting levels of iron.

21 December 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
LCLei Cui
Lei Cui
NHNa-Na Hou
Na-Na Hou
HWHong-Mei Wu
Hong-Mei Wu
XZXiang Zuo
Xiang Zuo
YLYi-Zhi Lian
Yi-Zhi Lian
JZJian-Hong Zhu
Jian-Hong Zhu
Background: Alzheimer's disease (AD) and Parkinson's disease (PD) are two major neurodegenerative diseases worldwide. Demographic aging is in rapid progress in China. Up-to-date estimates of AD and PD prevalence have not been provided.Methods: Studies that reported the prevalence of AD and PD in China were identified via a systematic database search from 1985 to 2018. Meta-analysis, local polynomial regression and autoregressive integrated moving average model were used for analyses.Results: A total of 99 studies were included in the study with populations of 385,312 and 227,228, respectively for AD and PD. The overall prevalence of AD and PD following age standardization was 3.20% [95% confidence interval (CI) = 3.17–3.23] and 1.06% (95% CI = 1.02–1.10), respectively in individuals over 60 years old. The rates increased drastically for every 10-years increment of age. The yearly prevalence of AD was predicted to increase from 3.81 to 6.17% in the next 5 years. Significant differences were observed between genders [male to female odds ratio (OR) for AD = 0.57, 95% CI = 0.51–0.64; OR for PD = 1.25, 95% CI = 1.06–1.46], and between education levels (Illiterate to non-illiterate OR for AD = 2.99, 95% CI = 2.38–3.75), but not between urban and rural settings.Conclusion: Our results provide an updated insight into the epidemiology of AD and PD in China and their associated rates and ratios. The findings may facilitate China policy makers and health professionals mitigate the related health issues.

1 September 2017 in International Immunopharmacology
Verified
Journal Article
Closed access
HFHui-Hui Fan
Hui-Hui Fan
LZLan-Bing Zhu
Lan-Bing Zhu
TLTing Li
Ting Li
HZHui Zhu
Hui Zhu
YWYa-Nan Wang
Ya-Nan Wang
XZXiong Zhang
Xiong Zhang

23 June 2017 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
XZXiong Zhang
Xiong Zhang
RYRui Yang
Rui Yang
BHBei-Lei Hu
Bei-Lei Hu
PLPengcheng Lu
Pengcheng Lu
LZLi-Li Zhou
Li-Li Zhou
JZJian-Hong Zhu
Jian-Hong Zhu
Aberrant expression of microRNA (miRNA) in tissues may lead to altered level in circulation. Considerable evidence has suggested that miRNA deregulation is involved in the pathogenesis of Parkinson’s disease (PD). In this study, we screened a set of PD-associated miRNAs and aimed to identify differentially expressed miRNAs in plasma of PD patients and to evaluate their potentiality to serve as PD biomarkers. A total of 95 subjects consisting of 46 sporadic PD cases and 49 controls were recruited. Plasma levels of six miRNAs including miR-433, miR-133b, miR-34b, miR-34c, miR-153 and miR-7 were evaluated using reverse transcribed quantitative PCR, among which we found that miR-34c and miR-7 were below detection limit under our condition. The results showed that levels of circulating miR-433 (P = 0.003) and miR-133b (P = 0.006), but not miR-34b and miR-153, were reduced in PD patients. miR-433 and miR-133b were strongly correlated in both control and PD groups (rs = 0.87 and 0.85, respectively). The correlation between miR-34b and miR-153 expressions was significantly reduced (P < 0.05) in the PD group. Although miR-433 and miR-133b were likely to be functionally complimentary as suggested by Pathway and Gene Ontology analyses, these two miRNAs per se might not be sufficient to predict PD. No correlation was observed between the four miRNAs and age or severity of disease. Collectively, our results demonstrate that circulating miR-433 and miR-133b are significantly altered in PD and may serve as PD biomarkers.

1 August 2020 in Chemosphere
Verified
Journal Article
Closed access
XZXiong Zhang
Xiong Zhang
HZHai-Qing Zhong
Hai-Qing Zhong
ZCZhong-Wei Chu
Zhong-Wei Chu
XZXiang Zuo
Xiang Zuo
LWLi Wang
Li Wang
HWHong-Mei Wu
Hong-Mei Wu

1 June 2019 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
XZXiong Zhang
Xiong Zhang
RLRong-Pei Liu
Rong-Pei Liu
WCWen-Hsing Cheng
Wen-Hsing Cheng
JZJian-Hong Zhu
Jian-Hong Zhu